Up 38.5%. 2012 Portfolio gain to date based on valuation increase less $1,850 interest
Up 33.1%. 2012 Portfolio gain to date based on return on invested capital
Up 15.1%. 2012 Pfizer stock price gain to date including three 22-cent dividends
Up 14.3%. S & P 500 gain to date (1,258 to 1,438)
Note: This portfolio had a steady cost basis of $100,000 from 11/17/04 inception through 6/2/08. From that date through mid-March of 2009, additional funds were invested until the cost basis reached $296,110. The basis has remained steady again since that time.
Note: This portfolio was up by as much as 96K pre-crash on 6/1/07 with the stock closing at $27.68 that day. It was also down as much as 333K on 3/2/09 when the stock closed at $11.66. Gains of 373K from inception were seen on 9/6/12 with the stock at $24.34. Current gains are 372K.
Note: Over time, the leverage factor at these portfolio levels is about 1.9, the lowest since inception.
Note: Average annualized gains from inception stands at 10.8% and considers all additional funds needed to margin the naked puts.